These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 6772908)

  • 1. Effects on EEG of the osmotic opening of the blood-brain barrier in rats.
    Fieschi C; Lenzi GL; Zanette E; Orzi F; Passero S
    Life Sci; 1980 Jul; 27(3):239-43. PubMed ID: 6772908
    [No Abstract]   [Full Text] [Related]  

  • 2. Evans blue distribution in the rate brain after intracarotid injection with the blood-brain barrier intact and open to osmosis.
    Kozler P; Pokorný J
    Sb Lek; 2003; 104(3):255-62. PubMed ID: 15224531
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Osmotic opening of the hematoencephalic barrier in experiments. Review].
    Kozler P
    Rozhl Chir; 2001 Aug; 80(8):393-6. PubMed ID: 11688240
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Osmotic opening of the blood-brain barrier and local cerebral glucose utilization.
    Pappius HM; Savaki HE; Fieschi C; Rapoport SI; Sokoloff L
    Ann Neurol; 1979 Mar; 5(3):211-9. PubMed ID: 443753
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Study with positron emission tomography of the osmotic opening of the dog blood-brain barrier for quinidine and morphine.
    Agon P; Kaufman JM; Goethals P; Van Haver D; Bogaert MG
    J Pharm Pharmacol; 1988 Aug; 40(8):539-43. PubMed ID: 2907006
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Blood-brain barrier disruption using mannitol: time course and electron microscopy studies.
    Cosolo WC; Martinello P; Louis WJ; Christophidis N
    Am J Physiol; 1989 Feb; 256(2 Pt 2):R443-7. PubMed ID: 2492773
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison and evaluation of osmotic blood-brain barrier disruption following intracarotid mannitol and methylglucamine iothalamate.
    Sage MR; Wilcox J; Evill CA; Benness GT
    Invest Radiol; 1982; 17(3):276-81. PubMed ID: 6811497
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Osmotic blood-brain barrier modification: monoclonal antibody, albumin, and methotrexate delivery to cerebrospinal fluid and brain.
    Neuwelt EA; Barnett PA; McCormick CI; Frenkel EP; Minna JD
    Neurosurgery; 1985 Sep; 17(3):419-23. PubMed ID: 3930991
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Reversible osmotic opening of the blood-brain barrier in mice.
    Fredericks WR; Rapoport SI
    Stroke; 1988 Feb; 19(2):266-8. PubMed ID: 2449747
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Influence of pregnancy on blood-brain barrier integrity during seizures in rats.
    Oztaş B; Kaya M; Camurcu S
    Pharmacol Res; 1993 Dec; 28(4):317-23. PubMed ID: 8140031
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of intracarotid hyperosmolar mannitol in triethyl tin (TET)-induced rat brain edema--preservation of blood-brain barrier (BBB) in TET edema.
    Inoue T; Nagara H; Kondo A; Fukui M; Tateishi J
    Brain Res; 1987 Jun; 414(2):309-13. PubMed ID: 3113663
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hyperosmolar opening of the blood-brain barrier in the energy-depleted rat brain. Part 1. Permeability studies.
    Greenwood J; Luthert PJ; Pratt OE; Lantos PL
    J Cereb Blood Flow Metab; 1988 Feb; 8(1):9-15. PubMed ID: 3123500
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Enhanced delivery of [125I]glial cell line-derived neurotrophic factor to the rat CNS following osmotic blood-brain barrier modification.
    Jiao S; Miller PJ; Lapchak PA
    Neurosci Lett; 1996 Dec; 220(3):187-90. PubMed ID: 8994224
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effects of the Na(+)/Ca(++) exchange blocker on osmotic blood-brain barrier disruption.
    Bhattacharjee AK; Nagashima T; Kondoh T; Tamaki N
    Brain Res; 2001 May; 900(2):157-62. PubMed ID: 11334793
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mannitol opening of the blood-brain barrier: regional variation in the permeability of sucrose, but not 86Rb+ or albumin.
    Brown RC; Egleton RD; Davis TP
    Brain Res; 2004 Jul; 1014(1-2):221-7. PubMed ID: 15213006
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Is there a therapeutic role for osmotic breaching of the blood-brain barrier?
    Fishman RA
    Ann Neurol; 1987 Sep; 22(3):298-9. PubMed ID: 3118761
    [No Abstract]   [Full Text] [Related]  

  • 17. The effects of magnesium sulfate on blood-brain barrier disruption caused by intracarotid injection of hyperosmolar mannitol in rats.
    Kaya M; Gulturk S; Elmas I; Kalayci R; Arican N; Kocyildiz ZC; Kucuk M; Yorulmaz H; Sivas A
    Life Sci; 2004 Nov; 76(2):201-12. PubMed ID: 15519365
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hyperosmotic blood-brain barrier disruption in brains of rats with an intracerebrally transplanted RG-C6 tumor.
    Inoue T; Fukui M; Nishio S; Kitamura K; Nagara H
    J Neurosurg; 1987 Feb; 66(2):256-63. PubMed ID: 3100731
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Entry of [3H]norepinephrine, [125I]albumin and Evans blue from blood into brain following unilateral osmotic opening of the blood-brain barrier.
    Chiueh CC; Sun CL; Kopin IJ; Fredericks WR; Rapoport SI
    Brain Res; 1978 Apr; 145(2):291-301. PubMed ID: 638788
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inability of dimethyl sulfoxide and 5-fluorouracil to open the blood-brain barrier.
    Neuwelt EA; Barnett P; Barranger J; McCormick C; Pagel M; Frenkel E
    Neurosurgery; 1983 Jan; 12(1):29-34. PubMed ID: 6219298
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.